Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: best news in the history of the company and management is going

SGE,

Im sure Swartz doesn't know everything as if he did we probably wouldn't be sitting at .50 but I'm pretty sure he knew that the patents were worth more than the $5-$6M million in debentures that he loaned us. In fact I believe PTSC had an independent appraisal conducted that valued the patents at $187M about 5 years ago. Im certain Swartz would (and proabably did) have done the same thing before loaning us any money. Also if S/L were not sure the patents were worth more than the $5-$6M there would be no reason to place a lean against them or for that matter loan us uncollaterized money. All I'm trying to say is they didn't take the kind of risk that warrants raping this company the way they have.

On another note I just wanted to say you and a few others here have been doing an outstanding job discussing details of the markman ruling. Thanks for simplifying some of the more complex legal questions the board has had over the last few months. Much appreciated.

Share
New Message
Please login to post a reply